UK markets close in 3 hours 10 minutes

Orthofix Medical Inc. (OFIX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
40.50-0.45 (-1.10%)
At close: 4:00PM EDT

Orthofix Medical Inc.

3451 Plano Parkway
Lewisville, TX 75056
United States
214 937 2000

IndustryMedical Devices
Full-time employees1,036

Key executives

NameTitlePayExercisedYear born
Mr. Jon C. SerbousekPres, CEO & Director1.57MN/A1961
Mr. Douglas C. RiceCFO & Chief Accounting Officer764.47kN/A1966
Ms. Kimberley A. EltingChief Legal & Devel. Officer761.61kN/A1965
Mr. Kevin J. KennyPres of Global Spine Bus.882.14kN/A1965
Mr. Paul W. GonsalvesPres of Global Orthofix Orthopedics309.65kN/A1966
Mr. Roberto DonadelloSr. VP, Global OperationsN/AN/AN/A
Dr. James T. Ryaby B.A., Ph.D., ChemistryChief Scientific OfficerN/AN/A1959
Mr. Dan E. YarbroughVP of Investor RelationsN/AN/AN/A
Ms. Jill MasonChief Ethics & Compliance OfficerN/AN/AN/A
Ms. Suzanne ArmstrongVP of HRN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Extremities. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Global Extremities segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.

Corporate governance

Orthofix Medical Inc.’s ISS governance QualityScore as of 1 July 2021 is 1. The pillar scores are Audit: 3; Board: 1; Shareholder rights: 2; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.